27
views
0
recommends
+1 Recommend
4 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      How to implement the framework for the elimination of mother-to-child transmission of HIV, syphilis, hepatitis B and Chagas (EMTCT Plus) in a disperse rural population from the Gran Chaco region: A tailor-made program focused on pregnant women

      meeting-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction The framework for the elimination of mother-to-child transmission (EMTCT Plus) was proposed by the Pan American Health Organization in 2017 to all member states in order to widen the already existing framework for HIV and syphilis to include elimination of the infection with hepatitis B virus (HBV) and Chagas disease (ChD), now called EMTCT Plus. The objective of this wider initiative is to achieve and maintain the elimination of mother-to-child transmission (MTCT) of the infection with HIV, syphilis, ChD, and the perinatal infection by HBV as a public health problem, in line with the Strategy for Universal Access to Health and Universal Health Coverage [1]. The EMTCT Plus framework represents an interesting challenge for member states, since it requires adequate implementation strategies to overcome health system diversities. Additionally, each country implements this framework in a different manner and according to their own national administrative structure, which can even vary within each country in federal administrations. Moreover, available data from each country constitute global national figures that do not necessarily reflect regional variations. This is the case of many intervention areas with dispersed rural populations like the Tri-Border Area between Argentina, Bolivia, and Paraguay located in the Gran Chaco region. Moreover, this region is a hotspot for neglected tropical diseases [2], not only for intestinal helminth infections but also for ChD [3]. This is the area that will be used as an example in the current tutorial to aid others in the implementation of the framework. For this purpose, we have posed a series of statements that aim to describe the different components, based on our experience, that should be considered for implementation of this framework. Aims of the EMTCT Plus framework for the Region of the Americas Reduction of the rate of MTCT of HIV to 2% or less Reduction of the incidence of MTCT of syphilis (including stillbirths) to 0.5 cases or less per 1,000 live births Reduction of hepatitis B antigen (HBsAg) prevalence among 4- to 6-year-old children to 0.1% or less More than 90% of children cured of Chagas infection with posttreatment negative serology. The prevention of MTCT of the infections included in the EMTCT Plus framework requires the application of different interventions directed specifically to women and their newborns before pregnancy and during pregnancy as well as after childbirth. Accordingly, a program for such an area needs to be designed bearing in mind the socioeconomic and environmental characteristics of the communities and centered on pregnant women and maternal-child health with a special focus on the opportunity of access to quality healthcare, the harmonization between the different levels of capacity of the health systems of the area, the concept of equity in access to health, and, ultimately, the strengthening of the healthcare capacities in the area in order to reach the proposed aims of EMTCT Plus (specific objectives are listed in Box 1). Since gender equality is a concept absolutely inherent to the context of the EMTCT Plus framework, the program needs to follow guidelines, norms, and practices related to sexual and reproductive health rights, women’s rights, and the health of their children. Box 1. Example of specific aims and objectives that can be formulated for a tailor-made program within the objectives of the EMTCT Plus framework: The case of the Tri-Border Area between Argentina, Bolivia, and Paraguay General program objective Collaborate in the implementation of the EMTCT Plus framework in a geographical delimitated area of the Tri-Border Area between Argentina, Bolivia, and Paraguay in the Gran Chaco region together with the local, regional, and national health systems of each country in order to strengthen local capacity and promote access to high quality healthcare practices. Specific program objectives Identify the health services that are offered in the communities that are located in the area of the study in order to obtain baseline data. Increase the coverage of pregnant women that receive checkups according to appropriate health practices to 100%. Identify and treat infections by HIV, syphilis, HBV, and ChD in pregnant women and newborns Identify high risk pregnancy for follow-up and eventual referral to more complex health centers, as needed Increase the number of institutional births in the communities that live in the intervention area. Optimize monitoring and follow-up of the quality of maternal-child health attention through the use of quality software to improve clinical management of those included in the program. Evaluate efficacy of the sanitary intervention model proposed. Characteristics of areas of the Americas with dispersed rural populations that need to be considered for implementation Geographic and climatic characteristics In the case of the Tri-Border Area, the program is implemented in rural and semi-urban communities from the municipality of Santa Victoria Este and the locality of Alto la Sierra in Salta Province (Argentina), the localities of Creavaux and D’Orbigny and close rural communities from the Autonomous Region of Chaco (Bolivia), and the localities of Pozo Hondo and San Agustín/Doctor Pedro P. Peña as well as close rural communities from the Department of Boquerón (Paraguay) (Fig 1). This region is characterized for presenting a subtropical climate with a dry season between the months of April and December and a very rainy season during the rest of the year. The region is crossed from east to west by the Pilcomayo River, which frequently overflows and causes floods, which lead to the isolation of the population living in the area. 10.1371/journal.pntd.0008078.g001 Fig 1 Map of the localities included in the intervention program. Santa Victoria Este and Alto la Sierra in Argentina, Colonia Crevaux and D´Orbigny in Bolivia, and Pozo Hondo and San Agustín/Doctor Pedro P. Peña in Paraguay. Map created with QGIS 2.4 open-source software. Population demographics and cultural characteristics The population living in the area of intervention, according to the census data from each community, is 23,059 inhabitants: 16,571 living in Argentina, 4,038 in Bolivia, and 2,450 in Paraguay. These communities are characterized by an important rural and disperse population with a strong presence of aboriginal ethnicities, predominately Wichi, Chorote, Chulupi, and Qom, [4] and multiple healthcare barriers to face in order to obtain high quality medical practices. This includes different cultural patterns [5] and geographical isolation, which tend to be the most relevant barriers. Moreover, centuries of isolation could explain the low demand of healthcare for this population and the consequent lack of basic health infrastructure. Characteristics of the local healthcare service Both Crevaux and D’Orbigny in Bolivia have their own primary healthcare centers, as do the localities of Pozo Hondo and San Agustín/Doctor Pedro P. Peña in Paraguay. In Argentina, there are numerous primary healthcare centers in different rural communities and localities as well as two hospitals located in Alto la Sierra y Santa Victoria Este (Fig 1; Table 1). The referral center for the communities of Bolivia is located in Yacuíba, 150 km away through a dirt road. Pozo Hondo and San Agustín/Pedro P. Peña are dependent on a hospital found in the locality of Mariscal Estigarribia, which is 300 km away on a dirt road. In Argentina, the hospital for the city of Tartagal is the closest to the area, and it is 150 km away from Santa Victoria Este on the only asphalt road in the entire area. Therefore, many of the inhabitants from these communities are rarely able to get to their referral centers on their own, and, in practice, many people from Bolivia and Paraguay cross the border to receive healthcare in Argentina due to proximity of hospitals with greater capacity including hospitalization. Additionally, the public health system in Argentina is universal and is not limited only to nationals or residents. Moreover, due to the different reasons mentioned above, the possibility of having specialized health personnel and access to an ultrasound and laboratory analysis under good laboratory practices are limited and has important variations between the three countries that comprise the area of intervention (Table 1). Another issue to consider is gratuity of the health service, which usually varies between countries. In other words, although the public health systems in Argentina, Bolivia, and Paraguay are completely free of charge for pregnant women and their children, the composition of the services provided are different for each country, and, in Bolivia, it requires certain out-of-pocket payments in order to have access to an ultrasound, for example. Moreover, in some of the localities, ultrasound or laboratory services are not available, and it is up to the patient to cover the costs to travel to an area where this service is provided. 10.1371/journal.pntd.0008078.t001 Table 1 Characteristics of the different health centers in the different localities within each country with respect to their medical staff, laboratory, and presence of an ultrasound machine. Country Locality Technical Staff (number) Medical Staff (number) Laboratory Ultrasound Argentina Santa Victoria Este Nurses (10) General practitioner (5) Yes Yes Alto la Sierra Nurses (4) General practitioner (2) Yes No El Mulato Nurses (1) None No No Bajo Grande None None No No San Miguel None None No No El Bravo Nurses (1) None No No La Esperanza None None No No Bolivia Creveaux Nurses (4) General practitioner (3) No No D´Orbigny Nurses (2) General Practitioner (1) No No Paraguay San Agustín/ Dr. Pedro P. Peña Nurses (2);Obstetric Technician (1) General Practitioner (1) No No Pozo Hondo Nurses (1) None No No Identification of the population to be included and of the professionals required for implementation Since the framework is centered on the MTCT of HIV, syphilis, HBV, and ChD, the first step for prevention included in the framework is sexual and reproductive health education. After that, implementation needs to be framed within general obstetric care, including the newborn and the postpartum phase. For this, a specialized team made up of a biochemist, an obstetrician and ultrasound technician, a general doctor, and a pediatrician is required. Logistical considerations that need to be taken into account for implementation Due to the geographic and healthcare service characteristics of the area, all actions need to be conducted in the community where the patients live. Therefore, the specialized health team is the one that moves, not the patients. This is so that all the clinical obstetric, pediatric and neonatology controls are performed in the field. Therefore, all the laboratory tests are based on rapid tests for measurement of glucose in blood, hemoglobin, blood group, and factor; serology for HIV, syphilis, HBV, and ChD; rapid detection of Streptococcus agalactiae after the 35th week of pregnancy; and ultrasound monitoring with a portable machine. Considerations to ensure patient follow-up during implementation In order to ensure patient follow-up, all of the actions are coordinated by a general coordination team, technical coordinators (biochemist, obstetrician, pediatrician, and data management coordinator), and co-coordinators of the health system according to the jurisdiction (Argentina, Bolivia, and Paraguay). Moreover, two types of actions need to be considered: periodic and continuous actions. Depending on the type of action, different teams of professionals are needed. Periodic actions Periodic actions are performed by the specialized team who works in an intensive manner for a short period of days (i.e., 5 straight days) with the support of other local professionals and health actors in a periodic manner (i.e., every 60 days). In the periodic visits, all the villages with higher populations and more rural populations should be visited in order to perform the following: clinical control of all pregnant women; ultrasound evaluation; serological testing for HIV, syphilis, HBV, and ChD; dosage of hemoglobin, glucose, blood type, and factor; return of results; collection of samples for confirmatory diagnosis in reference centers; treatment and/or pertinent clinical management of the diverse pathologies detected; coordination of referrals to specialized centers as needed; treatment and monitoring of puerperal women and newborns with diagnosis of an infection of vertical transmission; testing and treatment (as per guidelines and norms) of other children, siblings, and/or partners of pregnant women with a diagnosed infection of vertical transmission; training of local personnel; georeference of the households of all pregnant women, puerperal women, and nursing infants in the program; record of a local clinical history; electronic record with online management; and, finally, planning of actions for the following intervention. Continuous actions Continuous actions should be performed in a permanent manner on behalf of the local sanitary agents and should include registration of new pregnant women, follow-up of conducts and treatments put in place during the periodic actions, and online update of clinical records and data. Specific actions related to the different stages of a woman´s reproductive life need to be taken into account and are detailed in Box 2. Box 2. Specific actions related to the different stages of a women´s reproductive life that need to be performed in a continuous and permanent manner by the local sanitary agents and/or healthcare providers During pregnancy Pregnant women need to be actively sought out through the local sanitary or community agents in order to promote early and universal access to prenatal healthcare. The objective is for local professionals to start organizing appointments so that the women are seen by the specialized team during the periodic actions. All pregnant women need to have prenatal controls based on national guidelines. Serological screening for the detection of infection by HIV, syphilis, HBV through the HBsAg, and ChD, according to the trimester of pregnancy they are in and following national algorithms. Initially, rapid tests are performed, and those with positive results are confirmed by quantitative methods. Depending on the previous vaccination records of the pregnant woman, the vaccination calendar is updated. In Argentina, Bolivia, and Paraguay, a complete vaccination schedule includes a dose at birth within the first 12 hours of life and a booster dose at 2, 4, and 6 months of life. Treatment and follow-up of those pregnant women with positive serology for the EMTCT Plus infections Women with HIV infection receive standard antiretroviral treatment. Women with syphilis receive treatment with benzathine penicillin. Women with HBV infection are derived to a regional infectious disease service for evaluation and treatment group. Women with simultaneous infection with HIV and HBV receive antiretroviral treatment. Women with Trypanosoma cruzi infection are monitored until finalization of the pregnancy in order to organize their treatment following delivery as well as diagnosis and treatment of the newborn. Prenatal and postnatal period Newborns from HIV infected mothers receive prophylaxis according to current national norms during the first six weeks of birth. Nursing infants exposed to HIV will be tested for infection through the use of a blood PCR between the fourth and sixth week of birth, and a second sample will be taken and analyzed if the first sample was positive in order to confirm the diagnosis. Additionally, a rapid serological diagnosis test will be used for the detection of HIV antibodies at 18 months of life. All children infected with HIV will receive integral medical attention through referral to their reference center. Nursing infants with symptoms compatible with MTCT of syphilis or exposed to the risk of infection will be treated and monitored clinically and serologically in order to confirm seroconversion. Nursing infants of HBsAg-positive mothers will be evaluated for the presence of specific antigens for one to three months after completing the vaccination scheme. Additionally, the vaccination scheme against hepatitis B will be completed using the pentavalent vaccine following the national vaccination calendars: at 2, 4, and 6 months of age with a minimum interval of 4 weeks in between doses. Newborns of mothers’ positive for HBsAg will receive immunoglobulin specifically against hepatitis B (100 IU) in the first 12 hours after birth. All newborns will also receive the HBV vaccine in the first 12 to 24 hours after birth using the monovalent vaccine as per the national vaccination calendars. Newborns of T. cruzi infected mothers receive parasitological screening for the presence of the parasites through the use of a PCR in the postnatal period [7–11]. Newborns with positive PCR results start treatment. After birth, mothers receive counseling on family planning and contraception, and treatment with benznidazole is provided to those with positive serology for T. cruzi [12]. Those newborns of infected mothers with negative parasitology for T. cruzi in the postnatal period will be evaluated serologically for the presence of specific antibodies against the parasite at 10 months of age, when the maternal antibodies have waned. Children with positive serology for T. cruzi, will be treated with benznidazole before the first year of age, and their clinical management with serological monitoring will be performed as per national guidelines [6]. Management of patient data for implementation For the compilation of data and for them to be able to be used in an agile manner in order to be able to make decisions when seeing a patient, software that allows working in an offline manner was developed. This software is an open-source software called MySQL (Oracle Corporation), which is a type of relational database management system (RDBMS) that may be adapted to other contexts. Tablets are also used to allow for mobility and working in remote areas without connectivity. Recorded data are geolocalized in each tablet and then synchronized to a server that centralizes the information and allows online access from any device. Each operator has a username and password to access the system with different authorization levels, allowing either the viewing of clinical histories with follow-up visits and test results, the viewing and recording of data, or the viewing and recording of laboratory results. Moreover, the software allows the use of filters in order to be able to search for specific patients grouped by community, geographical area, age, pathology, and others and to be able to perform basic statistics. All actions are recorded in real time through tablets that are available at the sites where medical assistance is provided. In the same manner, all the data from complementary evaluations are entered either at the site or from the laboratories that perform the confirmatory tests. Data are accessible for project coordinators depending on the levels of assistance, and they are confidential. Moreover, different profiles of access are programmed so that depending on the role in the project, only certain parts of the data are available. For example, the authorities from the different countries only have access to the data from their own country. Other actions which need to be considered for implementation within the framework Due to the characteristics of the infections included in the framework, certain transversal actions need to be implemented. For infection by HIV, tests are offered for sexual partners and previous children of a seropositive woman. Positive individuals are referred to the closest jurisdictional greater complexity hospital for treatment and follow-up. For infection by HBV, a test for the detection of HBV (HBsAg) for sexual partners, children, siblings, and/or other family members and direct household contacts of people with a positive result should be conducted. Individuals with negative serology for HBAgs should be vaccinated as well as those that have never been vaccinated. For syphilis infection, treatment with benzathine penicillin (2.4 million units in a single dose, intramuscularly) for early syphilis or benzathine benzylpenicillin (2.4 million units weekly, intramuscularly) for three consecutive weeks for late syphilis or unknown stage should be given to all the partners of women positive for the infection. Transversal actions for ChD should include promotion measures to achieve the interruption of vector transmission in households and serological diagnosis of all previous children of pregnant women detected positive for T. cruzi infection. Any complex case that cannot be resolved in each locality is referred to the jurisdictional hospital with greatest complexity. This is the hospital of the city of Tartagal (160 km) for Argentina, the hospital of Mariscal Estigarribia (300 km) for Paraguay, and the hospital of Yacuíba (150 km) for Bolivia. Conclusion The protocol of a program centered on pregnant women and newborns is presented for the Tri-Border Area of Argentina, Bolivia, and Paraguay in the Gran Chaco region. This protocol has been implemented since June 2018 and has shown that it is feasible to undertake a public–private initiative in areas of high social and geographical vulnerability in three different countries with varying healthcare systems (Table 2 shows preliminary coverage data from the first year of implementation). This first implementation phase has also shown that it is possible to offer quality healthcare practices when there are tailor-made programs that specifically evaluate and address the needs of the target population. Finally, this program provides evidence that in order to be able to reach the goals of the EMTCT Plus framework, national strategies need to contemplate and adapt to local realities. The idea is for this project to serve as a model that may be implemented in other areas; although in order for the current project to be sustainable, one strategy that will be used in the second phase of the project is to incorporate and train regional medical doctors that can eventually take over the activities of the professional staff of the project. These would be professionals from Salta (Argentina) as well as from Bolivia and Paraguay. Furthermore, the local staff that is currently implementing the continuous activities is already trained and capable of continuing with these actions once the project is finalized. Ultimately, we hope that the information provided in this symposium piece is useful for implementation of the framework in similar areas. 10.1371/journal.pntd.0008078.t002 Table 2 Preliminary data from the first year of implementation. Country Census population Estimated number of pregnancies Number of controlled pregnancies 1 through implementation Coverage of pregnancies Argentina 16,571 392 2 485 124% Bolivia 4,038 89 3 79 4 88.8% Paraguay 2,450 41 47 114% Total 23,059 522 611 117% 1At least one complete evaluation was performed (including laboratory tests and ultrasound), since at the start of the project there were women in different trimesters of pregnancy. 2Data obtained from notified pregnancies for the specific area in 2017, prior to the start of the project. 3Number of pregnancies was estimated by using the birth rate for Bolivia and Paraguay (average annual number of births during a year per 1,000 persons in the population at midyear) from the Central Intelligence Agency factbook since official data from the specific areas is not available: https://www.cia.gov/library/publications/the-world-factbook/rankorder/2054rank.html. 4Two of the planned periodic visits could not be performed due to inclement weather. Key Learning Points Adding quality actions for prenatal control in the context of the EMTCT Plus framework made its implementation more effective and efficient. In order to implement the EMTCT Plus framework in dispersed populations that do not have the means to get to a referral center on their own or do not live in areas with local specialized health personnel, it is fundamental to rely on a local team (not necessarily highly trained) for patient uptake and follow-up. Counting with point-of-care diagnostics is imperative in order to be able to take immediate actions related not only to the patient but also to the family depending on the epidemiological situation (i.e., study of partners for sexually transmitted diseases or study of other children in the case of ChD). In remote areas, the adaptation of certain diagnostic and treatment norms is sometimes required in order to be able to adapt them to the local situation in which the distance to a referral center is not contemplated.

          Related collections

          Most cited references8

          • Record: found
          • Abstract: found
          • Article: not found

          Long term evaluation of etiological treatment of chagas disease with benznidazole.

          The aim of this article is to present an investigation of cure rate, after long follow up, of specific chemotherapy with benznidazole in patients with both acute and chronic Chagas disease, applying quantitative conventional serological tests as the base of the criterion of cure. Twenty one patients with the acute form and 113 with one or other of the various chronic clinical forms of the disease were evaluated, after a follow up period of 13 to 21 years, for the acute, and 6 to 18 years, for the chronic patients. The duration of the acute as well as the chronic disease, a condition which influences the results of the treatment, was determined. The therapeutic schedule was presented, with emphasis on the correlation between adverse reactions and the total dose of 18 grams, approximately, as well as taking into consideration precautions to assure the safety of the treatment. Quantitative serological reactions consisting of complement fixation, indirect immunofluorescence, indirect hemagglutination, and, occasionally, ELISA, were used. Cure was found in 76 per cent of the acute patients but only in 8 per cent of those with chronic forms of the disease. In the light of such contrasting results, fundamentals of the etiological therapy of Chagas disease were discussed, like the criterion of cure, the pathogenesis and the role of immunosuppression showing tissue parasitism in long standing chronic disease, in support of the concept that post-therapeutic consistently positive serological reactions mean the presence of the parasite in the patient's tissues. In relation to the life-cycle of T. cruzi in vertebrate host, there are still some obscure and controversial points, though there is no proof of the existence of resistant or latent forms. However, the finding over the last 15 years, that immunosuppression brings about the reappearance of acute disease in long stand chronic patients justifies a revision of the matter. Facts were quoted in favor of the treatment of chronic patients.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Ten Global “Hotspots” for the Neglected Tropical Diseases

            Since the founding of PLOS Neglected Tropical Diseases more than six years ago, I have written about the interface between disease and geopolitics. The neglected tropical diseases (NTDs) are the world's most common infections of people living in poverty [1]. Where they are widespread in affected communities and nations, NTDs can be highly destabilizing and ultimately may promote conflict and affect international and foreign policy [2]. Many of the published papers in this area were recently re-organized in a PLOS “Geopolitics of Neglected Tropical Diseases” collection that was posted on our website in the fall of 2012, coinciding with the start of our sixth anniversary [3]. From this information, a number of new and interesting findings emerged about the populations who are most vulnerable to the NTDs, including the extreme poor who live in the large, middle-income countries and even some wealthy countries (such as the United States) that comprise the Group of Twenty (G20) countries [4], as well as selected Aboriginal populations [5]. Together, the PLOS “Geopolitics of Neglected Tropical Diseases” collection and the G20 analyses identified more than a dozen areas of the world that repeatedly show up as ones where NTDs disproportionately affect the poorest people living at the margins. Here, I summarize what I view as ten of the worst global “hotspots” where NTDs predominate (Figure 1). They represent regions of the world that will require special emphasis for NTD control and elimination if we still aspire to meet Millennium Development Goals (MDGs) and targets by 2015; they are regions that may need to be highlighted again as we consider post-MDG aspirations and new Sustainable Development Goals (SDGs). 10.1371/journal.pntd.0002496.g001 Figure 1 Ten neglected tropical disease “hotspots” around the globe. The Americas In the Americas, there are at least three major zones where NTDs concentrate. Brazil and the Amazon Region In 2008, I found that Brazil has the largest number of NTDs in the Western hemisphere; they are particularly common among the millions of Brazilians who live on less than US$2 per day [6]. Brazil has almost all of the cases of blinding trachoma, leprosy, and schistosomiasis in the Americas, as well as most of the visceral leishmaniasis, hookworm, and dengue, and one-half of the ascariasis cases [6]. Lymphatic filariasis (LF) and onchocerciasis also occur, and Brazil has the largest number of Chagas disease cases in the world—1.9 million cases—although transmission of Chagas disease in the country has been greatly diminished or even eliminated [7]. Poverty reduction measures constituted an important component of former President Luiz Inácio Lula da Silva's administration and are subsequently being continued by President Dilma Roussef [8]. These measures include efforts at NTD control; however, it remains unclear the extent to which the total NTD burden has diminished over the last five to six years. Also in Brazil and immediately beyond its border is the Amazon region shared among the nations of Brazil, Colombia, Peru, Venezuela, Ecuador, Bolivia, Guyana, Suriname, and French Guiana, with a substantial but as-still-yet-unmeasured number of NTD cases and disease burden from Chagas disease, vivax malaria, arbovirus infections, leishmaniasis, and intestinal helminthiases. Gran Chaco Almost 10 million people inhabit the Gran Chaco, an area that spans eastern Bolivia, Paraguay, northern Argentina, and portions of two Brazilian states—Mato Grosso and Mato Grosso do Sul [9]. The area is an agriculturally intensive lowland region with a warm climate [9]. Among the major NTDs endemic to the region are intestinal helminth infections, including strongyloidiasis [10] and widespread Chagas disease [11] with triatomine insecticide resistance [12], although no disease burden information specifically for this region is available. Mesoamerica and Texas Mesoamerica includes Mexico's poorest states in the southern region, such as Chiapas, Guerrero, and Oaxaca [13], and impoverished Central American countries, such as El Salvador, Guatemala, Honduras, and Nicaragua. In Mexico, approximately 11 million people live in extreme poverty, with intestinal helminth infections, cysticercosis, cutaneous leishmaniasis (CL), and dengue representing the most common NTDs [13], [14], in addition to at least 1 million cases of Chagas disease [7], [14]. These same diseases are also widespread among the 30% of the population who live in extreme poverty in Central America [15], including approximately 800,000 cases of Chagas disease [7]. Although Texas is not generally considered a part of the Mesoamerican region, there is evidence that cysticercosis, CL, dengue, and even Chagas disease are widespread in South Texas and even in parts of Houston, which is emerging as the first major city in the United States with serious NTDs [16]. According to one estimate, Chagas disease results in almost US$1 billion in economic losses annually in the US [17]. Sub-Saharan Africa (SSA) SSA has a high concentration of NTDs globally, accounting for approximately one-quarter to one-third of the world's cases of the three major intestinal helminth infections (namely, ascariasis, trichuriasis, and hookworm infection), more than one-third of the LF, one-half of the trachoma, and all or most of the schistosomiasis, onchocerciasis, loiasis, and human African trypanosomaisis (HAT) [18]. Nigeria I have referred to Nigeria as “ground zero” for the NTDs because it ranks first in SSA in terms of the number of cases of all three intestinal helminth infections, schistosomiasis, LF, and onchocerciasis [18], [19]. Following publication of this information, the government of Nigeria redoubled efforts to expand NTD control and elimination efforts [20]. Democratic Republic of Congo (DRC) and Adjoining Nations: South Sudan, Central African Republic, Northern Uganda, and Angola DRC ranks closely behind Nigeria in terms of the total number of NTD cases, ranking second or third in most of the NTD disease categories and first in HAT and leprosy [18], [21]. DRC is still recovering from the last quarter of the 20th century when it was known as Zaire, during the reign of Mobutu Sese Seku, which was accompanied by the re-emergence of HAT and other diseases [21]. However, DRC is not alone, as long-standing conflicts and public health infrastructure declines in neighboring South Sudan, Central African Republic, northern Uganda, and Angola, may make this part of SSA one of the most NTD-affected regions in the world [18], [22]. South Sudan, which became an independent state in 2011, will likely soon become the last country to eradicate guinea worm infection [18]. Chad, Niger, and Mali and Adjoining Sahelian Areas These three adjoining nations have also suffered from widespread conflict and NTDs in recent years, and with it high rates of trachoma, schistosomiasis, and intestinal helminth infections [18], [23]. The nations of Niger and Mali are representative of the problem of high rates of NTDs occurring among selected nations of the Organisation of the Islamic Conference—the world's Islamic countries [23]. Still another region for strong consideration is among the southern and eastern African countries of Mozambique, Malawi, Tanzania, and Zimbabwe, where female urogenital schistosomiasis and other NTDs are widespread. Asia and Oceania The largest number of NTDs currently occurs in Asia, led by the large emerging market economies of India, Indonesia, and China [24]–[27]. Indonesia and Papua New Guinea Indonesia alone has approximately 10% of the world's cases of intestinal helminth infections, LF, and leprosy, in addition to more than one-half of the dengue deaths in Southeast Asia and a significant problem with other arbovirus infections and yaws [24]. Neighboring Papua New Guinea also accounts for most of the cases of hookworm infections and LF in Oceania, in addition to large numbers of cases of yaws and scabies, trachoma, leprosy, balantidiasis, and cholera outbreaks [25]. India and South Asia Nearly one-half or more of the cases of visceral leishmaniasis, LF, and leprosy occur in India and South Asia, in addition to one-third of the rabies deaths, one-quarter of the cases of intestinal helminth infections, and a massive but still ill-defined burden of disease from dengue and Japanese encephalitis [26]. China Rapid economic growth in eastern China has left behind high levels of disease and poverty in China's southwestern provinces of Sichuan, Guizhou, and Yunnan, where some of the highest rates of intestinal helminth infections are found [27]. China has the largest number of cases of the food-borne trematode infections, clonorchiasis, and paragonomiasis occurring in Guangdong Province in the South and some northern provinces, while more than 500,000 cases of schistosomiasis occur along the Yangtze River and its tributaries [27]. Trachoma and leprosy still occur [27]. A recent Global Burden of Disease analysis for China found that the NTDs are responsible for 3.7 million disability-adjusted life years (DALYs) lost annually, more than the DALYs lost from HIV/AIDS and tuberculosis [28]. The Middle East Approximately 65 million people live on less than US$2 per day in the Middle East and North Africa. These impoverished individuals suffer from high rates of intestinal helminthiases, LF, schistosomiasis, fascioloiasis, leishmaniasis, leprosy, and trachoma [29]. Overall, the highest rates of NTDs are found in Egypt and Yemen, but there are also a significant number of NTDs in Iran, Algeria, and elsewhere [28]. Concluding Comments These ten areas exhibit some of the world's highest concentrations of NTDs, although they vary with respect to having a modest prevalence among a large population versus hyperendemicity among a smaller population. Of interest is the finding that, with the important exception of SSA, they mostly include middle-income countries and nations belonging to the G20 [4]. The hotspot areas represent regions that require intensified efforts for NTD control and elimination, which would include access to essential NTD medicines through mass drug administration (also known as preventive chemotherapy), but also vector management and control. In a previous paper I pointed out the opportunities for the G20 countries to engage in scientific research and development to produce new drugs and vaccines affecting their regions, and possibly diplomacy to promote international scientific cooperation [4]. These regions would comprise key areas to target as a means to achieve the MDGs and to help set goals and targets past 2015 and for the new SDGs [30], [31]. This list represents a personal view of what I consider some of the most important NTD-affected areas in the world. I welcome comments and opinions from the NTD community on other regions and parts of the world I might have missed or where the readers believe there should be renewed emphasis for control and elimination.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The burden of congenital Chagas disease and implementation of molecular diagnostic tools in Latin America

              It is estimated that between 8000 and 15 000 Trypanosoma cruzi infected babies are born every year to infected mothers in Chagas disease endemic countries. Currently, poor access to and performance of the current diagnostic algorithm, based on microscopy at birth and serology at 8–12 months after delivery, is one of the barriers to congenital Chagas disease (CCD) control. Detection of parasite DNA using molecular diagnostic tools could be an alternative or complement to current diagnostic methods, but its implementation in endemic regions remains limited. Prompt diagnosis and treatment of CCD cases would have a positive clinical and epidemiological impact. In this paper, we analysed the burden of CCD in Latin America, and the potential use of molecular tests to improve access to early diagnosis and treatment of T. cruzi infected newborns.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS Negl Trop Dis
                PLoS Negl Trop Dis
                plos
                plosntds
                PLoS Neglected Tropical Diseases
                Public Library of Science (San Francisco, CA USA )
                1935-2727
                1935-2735
                28 May 2020
                May 2020
                : 14
                : 5
                : e0008078
                Affiliations
                [1 ] Fundación Mundo Sano, Buenos Aires, Argentina
                [2 ] Asociación para el Desarrollo Sanitario Regional (ADESAR), San Antonio de Areco, Buenos Aires, Argentina
                [3 ] Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno” (CEMIC), Buenos Aires, Argentina
                [4 ] Instituto de Parasitología “Dr. Mario Fatala Chaben,” Administración Nacional de Laboratorios e Institutos de Salud (ANLIS), Buenos Aires, Argentina
                [5 ] Centro Nacional de Diagnóstico e Investigaciones en Endemo-epidemias (CeNDIE), ANLIS, Buenos Aires, Argentina
                [6 ] Universidad Nacional de San Antonio de Areco, San Antonio de Areco, Buenos Aires, Argentina
                [7 ] Ministerio de Salud Pública de Salta, Salta, Argentina
                [8 ] Ministerio de Primera Infancia, Salta, Argentina
                [9 ] Dirección de Salud, Gobierno Autónomo Regional del Gran Chaco, Bolivia
                [10 ] XVI Región Sanitaria Boquerón, Ministerio de Salud Pública y Bienestar Social, Mariscal José Félix Estigarribia, Paraguay
                [11 ] Consejo Nacional de Investigaciones Científica y Técnicas (CONICET), Instituto de Investigaciones en Enfermedades Tropicales (IIET), Universidad de Salta – Sede Regional Orán, San Ramón de Orán, Salta, Argentina
                [12 ] Consejo Nacional de Investigaciones Científica y Técnicas (CONICET), Fundación Mundo Sano, Buenos Aires, Argentina
                University of Washington, UNITED STATES
                Author notes

                The authors have declared that no competing interests exist.

                Author information
                http://orcid.org/0000-0003-2385-7974
                http://orcid.org/0000-0002-1470-5146
                Article
                PNTD-D-19-00890
                10.1371/journal.pntd.0008078
                7255590
                32463835
                93163dbc-2006-4225-baed-5a43b31103d2
                © 2020 Crudo et al

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                Page count
                Figures: 1, Tables: 2, Pages: 10
                Funding
                Funded by: Fundación Mundo Sano
                Funded by: Asociación para el Desarrollo Sanitario Regional (ADESAR)
                The program is funded by Fundación Mundo Sano and Asociación para Desarrollo Sanitario Regional (ADESAR), both of which played a role in the program design and implementation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Symposium
                People and places
                Geographical locations
                South America
                Bolivia
                Medicine and health sciences
                Infectious diseases
                Viral diseases
                HIV infections
                People and places
                Geographical locations
                South America
                Argentina
                People and places
                Geographical locations
                South America
                Paraguay
                Medicine and Health Sciences
                Women's Health
                Maternal Health
                Pregnancy
                Medicine and Health Sciences
                Women's Health
                Obstetrics and Gynecology
                Pregnancy
                Medicine and Health Sciences
                Urology
                Genitourinary Infections
                Syphilis
                Medicine and Health Sciences
                Infectious Diseases
                Sexually Transmitted Diseases
                Syphilis
                Medicine and Health Sciences
                Infectious Diseases
                Bacterial Diseases
                Treponematoses
                Syphilis
                Medicine and Health Sciences
                Tropical Diseases
                Neglected Tropical Diseases
                Treponematoses
                Syphilis
                Medicine and Health Sciences
                Pathology and Laboratory Medicine
                Serology
                Biology and Life Sciences
                Developmental Biology
                Neonates

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article